Foghorn Therapeutics Inc.
FHTXNasdaqCIK 1822462HealthcareFiscal year ends Dec 31
Reports and events: 128 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-05-0611:03 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-020454 |
| 2024-05-0312:00 ET | DEF 14A | Proxy statementPeriod 2024-06-26 | 0001193125-24-129981 |
| 2024-04-1611:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-016281 |
| 2024-04-0920:41 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-015470 |
| 2024-03-0712:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-009540 |
| 2024-03-0712:09 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001628280-24-009539 |
| 2024-02-0812:04 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-003781 |
| 2024-01-1721:09 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-24-001504 |
| 2024-01-0812:04 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-000762 |
| 2024-01-0321:18 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-24-000199 |
| 2023-11-0211:08 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001628280-23-036187 |
| 2023-11-0211:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-23-036179 |
| 2023-09-0811:04 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-23-031771 |
| 2023-08-3111:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-23-031053 |
| 2023-08-1020:08 ET | 8-K | 1.02 Termination of a material agreement | 0001628280-23-028846 |
| 2023-08-0811:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-23-027933 |
| 2023-08-0411:08 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001628280-23-027402 |
| 2023-08-0411:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-23-027398 |
| 2023-06-2811:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-23-023671 |
| 2023-06-2220:13 ET | 8-K | 5.07 Shareholder vote results | 0001628280-23-023124 |
| 2023-06-0511:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-23-020737 |
| 2023-05-0811:05 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001628280-23-016255 |
| 2023-05-0811:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-23-016254 |
| 2023-04-2820:00 ET | DEF 14A | Proxy statementPeriod 2023-06-21 | 0001193125-23-126841 |
| 2023-04-2411:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-23-012499 |
| 2023-03-0921:07 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001628280-23-007297 |
| 2023-03-0912:12 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-23-007139 |
| 2023-03-0812:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-23-006887 |
| 2023-01-0912:07 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-23-000719 |
| 2022-11-0821:18 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001628280-22-028930 |
| 2022-11-0812:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-22-028753 |
| 2022-10-2711:08 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-22-027147 |
| 2022-10-2611:08 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-22-027017 |
| 2022-08-3120:12 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-22-024056 |
| 2022-08-2311:04 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-22-023462 |
| 2022-08-1711:08 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-22-023096 |
| 2022-08-0920:22 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001628280-22-021958 |
| 2022-08-0920:18 ET | 10-K/A | Annual report, amendedPeriod 2021-12-31 | 0001628280-22-021950 |
| 2022-08-0911:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-22-021736 |
| 2022-07-2811:20 ET | 10-Q/A | Quarterly report, amendedPeriod 2022-03-31 | 0001628280-22-019639 |
| 2022-06-2320:28 ET | 8-K | 5.07 Shareholder vote results | 0001628280-22-017905 |
| 2022-06-0811:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-22-016526 |
| 2022-05-1920:11 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-22-014872 |
| 2022-05-0920:22 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001628280-22-013333 |
| 2022-05-0911:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-22-013173 |
| 2022-04-2920:07 ET | DEF 14A | Proxy statementPeriod 2022-06-21 | 0001193125-22-133615 |
| 2022-04-1520:41 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-22-009351 |
| 2022-03-1022:09 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001628280-22-005753 |
| 2022-03-1012:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-22-005644 |
| 2022-01-1012:03 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-22-000561 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.